We’ve added a new summary of a dinner meeting discussing the evolving treatment landscape in ovarian cancer. The speakers included Professor Paul Cohen as Chair, Dr Aesha Gandhi who presented a session centred around a real-world patient case to illustrate the clinical rationale for PARP inhibitor use in ovarian cancer and Associate Professor Raj Mohan who provided an overview of pivotal clinical trials evaluating the role of primary debulking surgery in the management of advanced ovarian cancer.
Please login below to download this issue (PDF)